within Pharmacolibrary.Drugs.R_RespiratorySystem.R03D_OtherSystemicDrugsForObstructiveAirwayDiseases.R03DB06_EtamiphyllineAndAdrenergics;
model EtamiphyllineAndAdrenergics 
   extends Pharmacolibrary.Drugs.ATC.R.R03DB06;

  annotation(Documentation(
    info ="<html><body><p>Etamiphylline is a xanthine derivative used as a bronchodilator. It may be combined with adrenergics for the treatment of respiratory diseases such as asthma or chronic obstructive pulmonary disease (COPD). The fixed-dose combination is listed under the ATC code R03DB06. This combination is not in widespread use today and is not approved in most current regulatory settings.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies are available specifically for the combination of etamiphylline and adrenergics in humans. Estimates are provided based on typical properties of etamiphylline monotherapy in adults.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end EtamiphyllineAndAdrenergics;
